Promostem (human umbilical cord blood-derived mesenchymal stem cells)
/ Medipost
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 01, 2017
Follow-up Study of Safety and Efficacy in Subjects Who Completed NEUROSTEM® Phase-I/IIa Clinical Trial.
(clinicaltrials.gov)
- P1/2; N=45; Recruiting; Sponsor: Medipost Co Ltd.
New P1/2 trial • Alzheimer's Disease • Biosimilar • CNS Disorders
1 to 1
Of
1
Go to page
1